Cath Lab Navigation Aids

This channel includes news and new technology innovations for navigation aids to help guide interventional procedures. These include advanced imaging, fusion imaging, rotational angiograpy, fluoro overlay images, robotic systems, and 3D printing and holograms for use in the interventional lab or cath lab.

Systematic FFR Assessment Did Not Add Benefit During Diagnostic Angiography.
News | FFR Technologies | September 08, 2021
September 8, 2021 — Adding systematic fractional flow reserve (FFR) assessment to coronary angiography does not reduce...
Abbott's new interventional imaging platform powered by Ultreon 1.0 Software is a first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.

Abbott's new interventional imaging platform powered by Ultreon 1.0 Software is a first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.

News | Optical Coherence Tomography (OCT) | August 05, 2021
August 5, 2021 — The U.S. Food and Drug Administration (FDA) has cleared clearance Abbott's latest optical coherence...
The CathWorks angiography image derived FFR assessment system has received national reimbursement approval in Japan. The system uses a rotational angiography image dataset taken while the patient is in the cath lab to quickly reconstruct a 3-D coronary tree showing FFR numbers for all of the artery segments. 

The CathWorks angiography image derived FFR assessment system has received national reimbursement approval in Japan. The system uses a rotational angiography image dataset taken while the patient is in the cath lab to quickly reconstruct a 3-D coronary tree showing FFR numbers for all of the artery segments. 

News | FFR Technologies | July 26, 2021
July 26, 2021 – CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the...
An example of the Medis QCA angiography imaging derived fractional flow reserve (FFR) assessment. This technology removes the need for pressure wires and adenosine used in traditional FFR assessments of the coronary arteries.

An example of the Medis QCA angiography imaging derived fractional flow reserve (FFR) assessment. This technology removes the need for pressure wires and adenosine used in traditional FFR assessments of the coronary arteries.

News | Cath Lab | July 22, 2021
July 22, 2021 — Medis Medical Imaging is partnering with CORRIB Core Lab and Sinomed in randomized clinical trial of...
A live, 3-D intra-cardiac echo (ICE) ultrasound image from inside the atrium of the heart taken during the first cryoablation EP procedure performed using the technology at Northwestern Medicine. The new Philips Healthcare VeriSight Pro ICE catheter offers superior 2-D and 3-D live image guidance for a wide range of procedures in structural heart disease and electrophysiology (EP), allowing interventionalists to navigate procedures.

A live, 3-D intra-cardiac echo (ICE) ultrasound image from inside the atrium of the heart taken during the first cryo-ablation a EP procedure performed using the technology at Northwestern Medicine.

Feature | Ultrasound Intra-cardiac Echo (ICE) | July 21, 2021
July 21, 2021 — Northwestern Medicine Bluhm Cardiovascular Institute recently became the first cardiovascular program...
ICE image showing the inside of the heart. Mayo Clinic recently became the first to use the next-generation Philips 4-D intracardiac echo imaging catheter. ICE is seeing increased use in structural heart procedures.

ICE image showing the inside of the heart. Mayo Clinic recently became the first to use the next-generation Philips 4-D intracardiac echo imaging catheter. ICE is seeing increased use in structural heart procedures.

News | Ultrasound Intra-cardiac Echo (ICE) | July 16, 2021
July 16, 2021 — Mayo Clinic recently became the first to use a next-generation 4-D intracardiac echo (ICE) imaging...
CentraCare completed the first structural heart procedure in the world guided by a new 4-D hologram technology developed by EchoPixel. The augmented reality technology aims to reduce reduce procedure time, improve accuracy of the procedure, and reduce risk of complications.

CentraCare completed the first structural heart procedure in the world guided by a new 4-D hologram technology developed by EchoPixel. The augmented reality technology aims to reduce reduce procedure time, improve accuracy of the procedure, and reduce risk of complications.

Feature | Virtual and Augmented Reality | June 28, 2021
June 28, 2021 — CentraCare, one of the largest health systems in Minnesota, successfully completed the first structural...
The Philips Healthcare SyncVision system co-registers iFR hemodynamic blood flow measurements to live angiograms to enable easier assessment of which lesions in a vessel need to be stented and which can be left alone and treated medically.

The Philips Healthcare SyncVision system co-registers iFR hemodynamic  blood flow measurements to live angiograms to enable easier assessment of which lesions in a vessel need to be stented and which can be left alone and treated medically.

News | FFR Technologies | June 22, 2021
June 22, 2021 – Philips Healthcare announced the official start of the DEFINE GPS study, with the first patient being...
Some of the top technology news from ACC 2021. Top left, the LAAOS III trial showed benefit when surgeons seal off the LAA during other open heart procedures. Bottom left, the ReCor Paradise renal denervation system helped lower blood pressure in patients who did not respond to medication. Top right, for patients with both heart failure and AFib it makes no differences is therapy is focused on controlling the heart rhythm or heart rate. Bottom right, the FLOWER-MI trial found no benefit to FFR-guided PCI.

Some of the top technology news from ACC 2021. Top left, the LAAOS III trial showed benefit when surgeons seal off the LAA during other open heart procedures. Bottom left, the ReCor Paradise renal denervation system helped lower blood pressure in patients who did not respond to medication. Top right, for patients with both heart failure and AFib it makes no difference if therapy is focused on controlling the heart rhythm or heart rate. Bottom right, the FLOWER-MI trial found no benefit to FFR-guided PCI in STEMI with multi-vessel disease.

Feature | ACC | June 08, 2021 | By Dave Fornell, Editor
Here are the top 10 takeaways from the late-breaking studies on cardiovascular technologies presented at the 2021...
Videos | Congenital Heart | May 26, 2021
Tom Jones, M.D., director, cardiac catheterization laboratories, Seattle Children’s Hospital, explains some of the new...
Videos | Robotic Systems | May 18, 2021
Ehtisham Mahmud, M.D., division chief of cardiovascular medicine, director of interventional cardiology and the cardiac...
Videos | Robotic Systems | May 18, 2021
Ehtisham Mahmud, M.D., division chief of cardiovascular medicine, director of interventional cardiology and the cardiac...
The FLOWER-MI trial presented at ACC 2021 found no benefit to FFR-guided PCI in STEMI with multi-vessel disease. #ACC21 #ACC2021 #FFR

The FLOWER-MI trial presented at ACC 2021 found no benefit to FFR-guided PCI in STEMI with multi-vessel disease.

News | FFR Technologies | May 17, 2021
May 17, 2021 — In patients who received a coronary stent for an ST-elevation myocardial infarction (STEMI) heart attack...
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone. #SCAI21 #SCAI2021 Creating a card0-renal program.

There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone.

Feature | Cath Lab | May 14, 2021 | By Dave Fornell, Editor
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal...
Explaining the Emory TMVR angle. Discordance between mitral annular centerline (yellow lines) and valve orientation imposed by guidewire position within the LV apex (red dashed lines). (B) Valve intrinsic angle (α) is determined by external skirt height. (C) When annular-apical “Emory” angle (red curves) exceeds α (blue curve), annular skirt apposition is not possible, causing PVL (red arrows). (D) The valve is oriented perpendicular to the annual plane using an exteriorized apical guidewire.

Explaining the Emory TMVR angle. Discordance between mitral annular centerline (yellow lines) and valve orientation imposed by guidewire position within the LV apex (red dashed lines). (B) Valve intrinsic angle (α) is determined by external skirt height. (C) When annular-apical “Emory” angle (red curves) exceeds α (blue curve), annular skirt apposition is not possible, causing PVL (red arrows). (D) The valve is oriented perpendicular to the annual plane using an exteriorized apical guidewire (solid yellow line). Image courtesy of Kendra Grubb, M.D.

Feature | Structural Heart | May 13, 2021 | By Dave Fornell, Editor
The mitral valve anatomy is extremely complex, which has caused many challenges for transcatheter mitral valve...